A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Richel D. Mayberry et al.|Journal of Clinical Investigation|2022Cited by 33
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew L. Bootsma, Shuang G. Zhao, Rana R. McKay et al.|Journal of Clinical Oncology|2022Cited by 28
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extractionHannah M. Pezzi, David J. Beebe, David J. Guckenberger et al.|Lab on a Chip|2018Cited by 25
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M. Bade, Joshua M. Lang, Jennifer L. Schehr et al.|Molecular Oncology|2021Cited by 24
Prognostic value of integrated liquid biopsies in patients (pts) with metastatic urothelial cancer (mUC).Charlotte N. Stahlfeld, Joshua M. Lang, Hamid Emamekhoo et al.|Journal of Clinical Oncology|2023Cited by 1